ARCHIVES

Drug Approvals: FDA Grants Accelerated Approval to Imbruvica

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

Evidence “Weak” Linking EMFs, cancer

June 25, 1999

In Multi-Site Phase I Studies, No Investigator Sees All Toxicities

March 26, 2010

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995

Interview with Mark Ratain: Too Much Emphasis On Precision, Not Enough Emphasis On Accuracy In Dosing

October 8, 2010

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

June 14, 2013

CCOPs At Six Months: Sme Exceeding Patient Goals, Most Are Meeting Schedules

March 30, 1984